Innovace

Enalapril, the active ingredient in Innovace, is an ACE inhibitor presented as an oral tablet for oral use. It treats hypertension and heart failure in adult patients and is approved for use throughout the European Union.

GNH USA supplies Innovace as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Enalapril acts on the renin‑angiotensin‑aldosterone system to manage conditions related to elevated blood pressure and cardiac stress.

Hypertension: lowers systolic and diastolic pressure, reducing risk of stroke and myocardial infarction. Heart failure: improves symptoms, decreases hospitalisations, and prolongs survival. Post‑myocardial infarction: helps prevent adverse ventricular remodeling and lowers mortality. Diabetic nephropathy: slows progression of renal impairment in patients with type 2 diabetes.

Enalapril may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after standing. - Headache. - Fatigue or general weakness. - Nausea or mild gastrointestinal upset. - Taste disturbances.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure. - Hyperkalemia: elevated potassium levels. - Acute kidney injury: sudden decline in renal function. - Hepatic dysfunction: abnormal liver enzymes. - Neutropenia or agranulocytosis: reduced white blood cell counts.

Before initiating therapy with Enalapril, clinicians should assess patient history and monitor relevant parameters.

Monitor blood pressure: ensure adequate control without excessive hypotension. Assess renal function: check serum creatinine and eGFR periodically. Check electrolytes: especially potassium levels. Avoid use in pregnancy: contraindicated due to fetal toxicity. Use caution in elderly patients: increased sensitivity to hypotensive effects. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Enalapril can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Concomitant use with ARBs or aliskiren in diabetic patients: heightened risk of renal impairment. - Potassium‑sparing diuretics or potassium supplements: may cause dangerous hyperkalaemia. - Lithium: increased lithium concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect and affect renal function. - Loop or thiazide diuretics: can cause excessive blood pressure reduction. - Beta‑blockers: additive hypotensive effect requiring dose adjustments.